Catalyst Wire Dossier Catalyst Wire Dossier

R2-ICE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R2-ICE, covering 2021-09-20 to 2021-09-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL [Phase 2]

See pricing